Maria Celeridad

429 total citations
8 papers, 152 citations indexed

About

Maria Celeridad is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Maria Celeridad has authored 8 papers receiving a total of 152 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Immunology. Recurrent topics in Maria Celeridad's work include Protein Tyrosine Phosphatases (4 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Microtubule and mitosis dynamics (2 papers). Maria Celeridad is often cited by papers focused on Protein Tyrosine Phosphatases (4 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Microtubule and mitosis dynamics (2 papers). Maria Celeridad collaborates with scholars based in United States, Germany and Switzerland. Maria Celeridad's co-authors include Nicholas D. P. Cosford, Lester J. Lambert, Douglas J. Sheffler, Lutz Tautz, A. Chaikuad, Weiming Xu, Sabita Sankar, Stefan Knapp, Brydon L. Bennett and David R. Webb and has published in prestigious journals such as Journal of Biological Chemistry, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Maria Celeridad

8 papers receiving 150 citations

Peers

Maria Celeridad
Chenxiang Tang United States
Bing Hu China
Abigail L. Thorpe United States
Adriana Kita United States
Tanya R. Blane United States
Maria Celeridad
Citations per year, relative to Maria Celeridad Maria Celeridad (= 1×) peers Alamelu Chandrasekaran

Countries citing papers authored by Maria Celeridad

Since Specialization
Citations

This map shows the geographic impact of Maria Celeridad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Celeridad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Celeridad more than expected).

Fields of papers citing papers by Maria Celeridad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Celeridad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Celeridad. The network helps show where Maria Celeridad may publish in the future.

Co-authorship network of co-authors of Maria Celeridad

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Celeridad. A scholar is included among the top collaborators of Maria Celeridad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Celeridad. Maria Celeridad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Chaikuad, A., Allison S. Limpert, Lester J. Lambert, et al.. (2021). Inhibitors of the Hippo Pathway Kinases STK3/MST2 and STK4/MST1 Have Utility for the Treatment of Acute Myeloid Leukemia. Journal of Medicinal Chemistry. 65(2). 1352–1369. 23 indexed citations
2.
Lambert, Lester J., Stefan Grotegut, Maria Celeridad, et al.. (2021). Development of a Robust High-Throughput Screening Platform for Inhibitors of the Striatal-Enriched Tyrosine Phosphatase (STEP). International Journal of Molecular Sciences. 22(9). 4417–4417. 11 indexed citations
3.
Pache, Lars, Matthew D. Marsden, Peter Teriete, et al.. (2020). Pharmacological Activation of Non-canonical NF-κB Signaling Activates Latent HIV-1 Reservoirs In Vivo. Cell Reports Medicine. 1(3). 100037–100037. 38 indexed citations
4.
Lambert, Lester J., Douglas J. Sheffler, Raveendra-Panickar Dhanya, et al.. (2020). A cellular target engagement assay for the characterization of SHP2 (PTPN11) phosphatase inhibitors. Journal of Biological Chemistry. 295(9). 2601–2613. 16 indexed citations
5.
Lambert, Lester J., et al.. (2020). Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors. Journal of Visualized Experiments. 2 indexed citations
6.
Vamos, Mitchell, A. Chaikuad, Allison S. Limpert, et al.. (2020). Design, Synthesis, and Characterization of an Orally Active Dual-Specific ULK1/2 Autophagy Inhibitor that Synergizes with the PARP Inhibitor Olaparib for the Treatment of Triple-Negative Breast Cancer. Journal of Medicinal Chemistry. 63(23). 14609–14625. 39 indexed citations
7.
Lambert, Lester J., et al.. (2020). Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors. Journal of Visualized Experiments. 1 indexed citations
8.
Xu, Weiming, Maria Celeridad, Sabita Sankar, David R. Webb, & Brydon L. Bennett. (2008). CC-4047 promotes Th1 cell differentiation and reprograms polarized human Th2 cells by enhancing transcription factor T-bet. Clinical Immunology. 128(3). 392–399. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026